This Day On The Street
Continue to site
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here

Icahn Pushes For Board Seats At Commercial Metals

IRVING, Texas (AP) â¿¿ Commercial Metals Co. said Wednesday that billionaire investor Carl Icahn is pushing to have three associates elected to its board and do away with a shareholder rights plan that is blocking a hostile takeover of the struggling steel-parts company.

The announcement pushed the Irving-based company's shares up almost 6 percent in after-hours trading Wednesday.

Commercial Metals said that it had received notice that Icahn intends to nominate three people to its board at its 2012 annual meeting.

Icahn amassed an almost 10 percent stake in Commercial Metals this July after first buying up the stock last August. Days after his stake was revealed, the company adopted a so-called poison pill defense that would be triggered whenever any hostile acquirer gets a stake in the company exceeding 10 percent.

CEO Joe Alvarado said the board and management "always welcome constructive dialogue with stockholders and we regularly review all options for generating and delivering value."

"In what continues to be a challenging environment for the entire steel industry, we have taken aggressive steps to improve operational and financial performance regardless of market conditions," it said.

Earlier this month, Commercial Metals said it plans to sell or close a number of facilities, leading to the loss of 1,500 jobs, most of them at a steel pipe manufacturing plant in Croatia.

Icahn's nominees are James Unger, 63, the former CEO of American Railcar Industries Inc.; Steve Mongillo, 50, a private investor and director of American Railcar; and George Hebard, 38, a managing director at Icahn Capital. Icahn Capital is the majority owner of American Railcar.

Icahn also put several shareholder proposals forward, including ones that would require majority shareholder support for any poison pill and repeal the one the company enacted in July.
Copyright 2011 Associated Press. All rights reserved. This material may not be published, broadcast, rewritten or redistributed.

Check Out Our Best Services for Investors

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
14-Days Free
Only $9.95
14-Days Free
Dividend Stock Advisor

David Peltier identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Updates with exact steps to take - BUY, HOLD, SELL
Trifecta Stocks

Every recommendation goes through 3 layers of intense scrutiny—quantitative, fundamental and technical analysis—to maximize profit potential and minimize risk.

Product Features:
  • Model Portfolio
  • Intra Day Trade alerts
  • Access to Quant Ratings
Real Money

More than 30 investing pros with skin in the game give you actionable insight and investment ideas.

Product Features:
  • Access to Jim Cramer's daily blog
  • Intraday commentary and news
  • Real-time trading forums
Only $49.95
14-Days Free
14-Days Free
AAPL $95.01 1.05%
FB $97.75 -6.10%
GOOG $682.74 -0.12%
TSLA $142.31 -12.00%
YHOO $27.05 -3.29%


Chart of I:DJI
DOW 16,027.05 -177.92 -1.10%
S&P 500 1,853.44 -26.61 -1.42%
NASDAQ 4,283.7530 -79.3910 -1.82%

Free Reports

Top Rated Stocks Top Rated Funds Top Rated ETFs